Get startedLog in
    Picture of Zydus Lifesciences logo

    ZYDUSLIFE — Zydus Lifesciences Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Zydus Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    R2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line14,95422,84828,38125,89748,089
    Depreciation
    Non-Cash Items7,6815,070-1,6275,163-999
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-4,546-3,315-13,333-11,399-22,392
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities25,05431,85120,78226,88832,339
    Capital Expenditures-9,041-8,540-12,026-10,309-9,066
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-1,0821,31523,57025,659-5,686
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-10,123-7,22511,54415,350-14,752
    Financing Cash Flow Items-287-3,233-1,111-1,262-729
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-10,942-25,489-8,683-44,004-18,104
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash3,989-90523,729-1,700-748